Anavex Life Sciences Corp (AVXL)

[Aero-man]

Hurdles for the sake of hurdles are one thing (as we see with all bureaucracy including the FDA), necessary and justifiable hurdles are another.

And lets not forget that due to FDA activity or lack thereof, the cabal of shorts and game-players have had a heyday with this stock’s share price for 2.5 years – they know how to play the game in an environment nurtured by big bureaucracy.